2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2004060458v1 16/8/2346    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ullian, M. E. Articles by Morinelli, T. A. Search for Related Content PubMed PubMed Citation Articles by Ullian, M. E. Articles by Morinelli, T. A.

N-Acetylcysteine Decreases Angiotensin II Receptor Binding in Vascular Smooth Muscle Cells

Medical University of South Carolina, Ralph H. Johnson Veterans Administration Hospital, Charleston, South Carolina

Address correspondence to: Dr. Michael E. Ullian, Medical University of South Carolina, Division of Nephrology, CSB 829, 96 Jonathan Lucas Street, P.O. Box 250623, Charleston, SC 29425. Phone: 843-792-4123; Fax: 843-792-8399; E-mail: ullianme{at}musc.edu

Received for publication June 9, 2004. Accepted for publication April 24, 2005.

Antioxidants seem to inhibit angiotensin II (Ang II) actions by consuming stimulated reactive oxygen species. An alternative hypothesis was investigated: Antioxidants that are also strong reducers of disulfide bonds inhibit the binding of Ang II to its surface receptors with consequent attenuation of signal transduction and cell action. Incubation of cultured vascular smooth muscle cells, which possess Ang II type 1a receptors, with the reducing agent n-acetylcysteine (NAC) for 1 h at 37°C resulted in decreased Ang II radioligand binding in a concentration-dependent pattern. NAC removal restored Ang II binding within 30 min. Incubation with n-acetylserine, a nonreducing analogue of NAC, did not lower Ang II binding, and oxidized NAC was less effective than reduced NAC in lowering Ang II binding. NAC did not decrease Ang II type 1a receptor protein content. Other antioxidants regulated Ang II receptors differently: -Lipoic acid lowered Ang II binding after 24 h, and vitamin E did not lower Ang II binding at all. NAC inhibited Ang II binding in cell membranes at 21 or 37 but not 4°C. Dihydrolipoic acid (the reduced form of -lipoic acid), which contains free sulfhydryl groups as NAC does, decreased Ang II receptor binding in cell membranes, whereas -lipoic acid, which does not contain free sulfhydryl groups, did not. Ang II–stimulated inositol phosphate formation was decreased by preincubation with NAC (1 h) or -lipoic acid (24 h) but not vitamin E. In conclusion, certain antioxidants that are reducing agents lower Ang II receptor binding, and Ang II–stimulated signal transduction is decreased in proportion to decreased receptor binding.

This article has been cited by other articles:

				M. H. M. Shimizu, A. Danilovic, L. Andrade, R. A. Volpini, A. B. Liborio, T. R.C. Sanches, and A. C. Seguro N-acetylcysteine protects against renal injury following bilateral ureteral obstruction Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3067 - 3073. [Abstract] [Full Text] [PDF]

				N. Schupp, U. Schmid, P. Rutkowski, U. Lakner, N. Kanase, A. Heidland, and H. Stopper Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1427 - F1434. [Abstract] [Full Text] [PDF]

				C. Ruster and G. Wolf Renin-Angiotensin-Aldosterone System and Progression of Renal Disease J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2985 - 2991. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673